By Karim Kassam, Senior Director of Technical and Scientific Services at ACD/Labs
Last week, we announced updates across our suite of informatics software! These improvements deliver enhanced functionality to a number of offerings on the ACD/Spectrus and ACD/Percepta Platforms. The updates also includes the introduction of our all-new metabolite identification solution, MetaSense.
This announcement is really important to our team and speaks to the company’s foundational mission. By continually refining and producing innovative software, we are able to help you do your best work and be able to rely on data-driven decision making when addressing R&D challenges. As we approach 23 years of serving customers on a global scale, we are always paying close attention to leading advancements in the analytical and chemistry knowledge management space. Our recent updates reflect current industry-standards, such as data visualization and expanded database search capabilities, to ensure our customers stay on top of the latest technologies, trends and initiatives to be successful in the lab.
In addition to the extensive list of updates we made to our signature ACD/Spectrus and ACD/Percepta platforms, we are especially proud of our new MetaSense solution—which automatically creates highly interactive, contextual biotransformation maps in which metabolite structures are associated with live-spectral and chromatographic data. MetaSense provides an unparalleled solution to scientists working in metabolite identification for visualization of results and as a decision-support platform for review and interrogation of projects. This tremendously reduces the burden of reporting complex data to PDF, Word, and Excel.
If you’d like to learn more about the specific features included in ACD/Labs' V2016.1 software updates, please visit: www.acdlabs.com/support/version/.